Trade Summary

3 days ago, Barber Daniel, serving as President and CEO at Aquestive Therapeutics, Inc. (AQST), sold 25,000 shares at $4.16 per share, for a total transaction value of $104,010.00. Following this transaction, Barber Daniel now holds 635,574 shares of AQST.

This sale represents a 3.78% decrease in Barber Daniel's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, June 15, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 16, 2026 at 4:09 PM ET, 1 day after the trade was made.

Aquestive Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.